Home

Orbimed Advisors reported a 0% stake in Vistagen Therapeutics VTGN · 0 sh · amendment · passive holder

Trade details

Type
5% stake report
Report
13G passive · amendment
Stake
0%
Last report
4.2% · filed 26/02/17
Shares held
0 sh
Class
Common Stock, par value $0.001 per share
Event date
26/06/30
Filed
26/08/14

0% stake · fully exited

Stake
0%
Last report
4.2%
Since last report
−4.2pp

Vistagen Therapeutics trades, last 26 weeks

What else happened in Vistagen Therapeutics around then

Filed or reported within 30 days of the trade day · 05/31~07/30

Orbimed Advisors's other 5% stake reports

  • Orbimed Advisors

    5% stakeElectra Therapeutics

    11% stake

    Filed 09/25

  • Orbimed Advisors

    5% stakeBraveheart Bio

    13.5% stake

    Filed 09/10

  • Orbimed Advisors

    5% stakeBraveheart Bio

    17.2% stake

    Filed 08/18

  • Orbimed Advisors

    5% stakeBlossomHill Therapeutics

    8.9% stake

    Filed 08/18

  • Orbimed Advisors

    5% stakeWhitehawk Therapeutics

    7.3% stake

    Filed 08/14